Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      123 trials found

      Recruiting (123)
      Not yet recruiting
      Recruiting
      NCT05253651
      A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

      Colorectal Neoplasms

      Male or Female
      18+ years
      389study location(s)
      Recruiting
      NCT06758401
      This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

      Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

      Male or Female
      18+ years
      46study location(s)
      Recruiting
      NCT06952660
      Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

      Cervical Cancer

      Females
      18+ years
      19study location(s)
      Recruiting
      NCT06152575
      MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

      Multiple Myeloma

      Male or Female
      18+ years
      223study location(s)
      Recruiting
      NCT05317416
      Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

      Multiple Myeloma

      Male or Female
      18+ years
      222study location(s)
      Recruiting
      NCT06215118
      A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

      Multiple Myeloma

      Male or Female
      18+ years
      35study location(s)
      Recruiting
      NCT06966453
      A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

      Breast Cancer, Breast Neoplasms

      Male or Female
      18+ years
      6study location(s)
      Recruiting
      NCT07013474
      A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

      COVID-19 Infection

      Male or Female
      18+ years
      23study location(s)
      Recruiting
      NCT06679140
      A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

      COVID-19 SARS-CoV-2 Infection

      Male or Female
      12+ years
      122study location(s)
      Recruiting
      NCT05261139
      EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

      COVID-19

      Male or Female
      Up to 17 years
      73study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting (123)
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.